JP2013500996A5 - - Google Patents

Download PDF

Info

Publication number
JP2013500996A5
JP2013500996A5 JP2012523087A JP2012523087A JP2013500996A5 JP 2013500996 A5 JP2013500996 A5 JP 2013500996A5 JP 2012523087 A JP2012523087 A JP 2012523087A JP 2012523087 A JP2012523087 A JP 2012523087A JP 2013500996 A5 JP2013500996 A5 JP 2013500996A5
Authority
JP
Japan
Prior art keywords
oxazine
imidazo
dihydro
nitro
trifluoromethoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012523087A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013500996A (ja
JP5781072B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/043906 external-priority patent/WO2011014774A1/en
Publication of JP2013500996A publication Critical patent/JP2013500996A/ja
Publication of JP2013500996A5 publication Critical patent/JP2013500996A5/ja
Application granted granted Critical
Publication of JP5781072B2 publication Critical patent/JP5781072B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012523087A 2009-07-31 2010-07-30 ニトロイミダゾオキサジンおよび抗−結核療法におけるその使用 Expired - Fee Related JP5781072B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23039609P 2009-07-31 2009-07-31
US61/230,396 2009-07-31
PCT/US2010/043906 WO2011014774A1 (en) 2009-07-31 2010-07-30 Nitroimidazooxazines and their uses in anti-tubercular therapy

Publications (3)

Publication Number Publication Date
JP2013500996A JP2013500996A (ja) 2013-01-10
JP2013500996A5 true JP2013500996A5 (https=) 2013-09-12
JP5781072B2 JP5781072B2 (ja) 2015-09-16

Family

ID=42937154

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012523087A Expired - Fee Related JP5781072B2 (ja) 2009-07-31 2010-07-30 ニトロイミダゾオキサジンおよび抗−結核療法におけるその使用

Country Status (12)

Country Link
EP (1) EP2459571B1 (https=)
JP (1) JP5781072B2 (https=)
KR (1) KR101746482B1 (https=)
CN (1) CN102753558B (https=)
AU (1) AU2010278777B2 (https=)
BR (1) BR112012002278A2 (https=)
CA (1) CA2769359C (https=)
ES (1) ES2536997T3 (https=)
IN (1) IN2012DN01414A (https=)
NZ (1) NZ598121A (https=)
RU (1) RU2542988C2 (https=)
WO (1) WO2011014774A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5916739B2 (ja) * 2011-04-15 2016-05-11 大塚製薬株式会社 6,7−ジヒドロイミダゾ[2,1−b][1,3]オキサジン化合物
CN104059082B (zh) * 2013-03-21 2016-08-03 苏州迈泰生物技术有限公司 硝基咪唑杂环类化合物及其在制备治疗结核病药物中的应用
KR101682356B1 (ko) 2014-11-04 2016-12-06 한국화학연구원 이미다조 옥사진 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학이성질체 및 이를 유효성분으로 함유하는 약제학적 조성물
CN107207532B (zh) 2015-01-29 2019-07-30 南京明德新药研发股份有限公司 抗肺结核病的硝基咪唑衍生物
CN108047248A (zh) * 2018-02-12 2018-05-18 丹诺医药(苏州)有限公司 噁唑烷酮-硝基咪唑类偶联分子的应用
CN113527331B (zh) * 2020-04-17 2024-05-28 南京长澳医药科技有限公司 硝基咪唑类衍生物及其制备方法和用途
CN113355439A (zh) * 2021-06-07 2021-09-07 深圳市普瑞康生物技术有限公司 一种结核分枝杆菌潜伏感染及发病的新型组合检测方法
CN114469946B (zh) * 2022-02-24 2023-10-24 首都医科大学附属北京胸科医院 德拉马尼作为cxcl10抑制剂的用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100342761B1 (ko) 1994-03-08 2002-12-06 와이어쓰 항과혈당제로서의 티아졸리딘디온 유도체
US5668127A (en) * 1995-06-26 1997-09-16 Pathogenesis Corporation Nitroimidazole antibacterial compounds and methods of use thereof
US6087358A (en) * 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
TWI347946B (en) * 2002-10-11 2011-09-01 Otsuka Pharma Co Ltd 2,3-dihydro-6-nitroimidazo[2,1-b]oxazole compound
UA91822C2 (ru) * 2003-10-31 2010-09-10 Оцука Фармасьютикел Ко., Лтд. СОЕДИНЕНИЕ 2,3-ДИГИДРО-6-НИТРОИМИДАЗО[2,1-b]ОКСАЗОЛА ДЛЯ ЛЕЧЕНИЯ ТУБЕРКУЛЕЗА
ATE382609T1 (de) 2004-01-16 2008-01-15 Sumitomo Chemical Co Malononitrilverbindungen als pestizide
TWI300409B (en) * 2004-02-18 2008-09-01 Otsuka Pharma Co Ltd Method for producing 4-nitroimidazole compound
WO2006043121A1 (en) * 2004-10-20 2006-04-27 Ranbaxy Laboratories Limited Oxazolidinone derivatives as antimicrobials
KR20080038369A (ko) * 2005-07-28 2008-05-06 버텍스 파마슈티칼스 인코포레이티드 카스파제 억제제 프로드럭
US20080275035A1 (en) 2005-12-23 2008-11-06 Jan Jiricek Nitroimidazole Compounds
CA2712613C (en) * 2008-03-26 2017-02-28 Global Alliance For Tb Drug Development Bicyclic nitroimidazoles covalently linked to substituted phenyl oxazolidinones

Similar Documents

Publication Publication Date Title
JP2013500996A5 (https=)
JP2013500997A5 (https=)
RU2012107176A (ru) Нитроимидазооксазины и их применения при противотуберкулезной терапии
de Souza Promising drugs against tuberculosis
US11345694B2 (en) Antibacterial compounds
JP2014530900A5 (https=)
RU2011121567A (ru) Изоиндолиновые соединения для применения при лечении рака
JP2016517417A5 (https=)
JP2014037426A5 (https=)
JP2014519518A5 (https=)
JP2015514794A5 (https=)
JP2015501833A5 (https=)
JP2015521634A5 (https=)
JP2016538313A5 (https=)
CA2412968A1 (en) Substituted pyridines as selective cyclooxygenase-2 inhibitors
JP2020521730A5 (https=)
JP2018501315A5 (https=)
JP2014518267A5 (https=)
JP2011502982A5 (https=)
RU2019111882A (ru) Антагонисты trpv4
JP2017523215A5 (https=)
JP2017529389A5 (https=)
RU2014115290A (ru) Производные 1-фенил 2-пиридинилалкиловых спиртов в качестве ингибиторов
JP2018508553A5 (https=)
RU2011118497A (ru) Оксазолидиниловые антибиотики